2Cervera A,Chamorro A. Antithrombotic therapy in cardi- ac embolism[J]. Curr Cardiol Rev,2010,6(3) :227-237.
3Altman R,Vidal HO. Battle of oral anticoagulants in the field of atrial fibrilation scrutinized from a clinical practice (the real world) perspeetive[J]. Thromb J, 2011,9 ( 1 ) : 12.
4Shen AY, Yao JF, Brar SS, ct al. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation[J]. J Am Coll Cardiol, 2007,50 (4) : 309- 315.
7Uresandi F,Iruin G,Gómez B,et al.Follow-up of pulmonary thromboembolism[J].Med Clin,2008; 131(Suppl.2):S54-S59.
8Campbell IA,Bentley DP,Prescott RJ,et al.Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism,or both:randomised trial[J].BMJ,2007; 334:674-680.
9Sam S.Is 3 months the optimum duration of anticoagulation therapy for deep vein thrombosis and pulmonary embolism[J].Sat Clin Pract Cardiovasc Med,2007; 4:472 -473.
10Haspel J,Bauer K,Goehler A,et al.Long-term anticoagulant therapy for idiopathic pulmonary embolism in the elderly:A decision analysis[J].Chest,2009; 135:1243-1251.
2Francesca R Ponziani,Maria A Zocco,Chiara Campanale,Emanuele Rinninella,Annalisa Tortora,Luca Di Maurizio,Giuseppe Bombardieri,Raimondo De Cristofaro,Anna M De Gaetano,Raffaele Landolfi,Antonio Gasbarrini.Portal vein thrombosis:Insight into physiopathology,diagnosis,and treatment[J].World Journal of Gastroenterology,2010,16(2):143-155. 被引量：80
